NDC 50090-7276-01 - Acyclovir

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
50090-7276
Requested NDC
50090-7276-01
Package NDCs from labels
50090-7276-0, 50090-7276-1, 50090-7276-01
Manufacturer
A-S Medication Solutions
Effective date
2024-10-14
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Acyclovir - A-S Medication SolutionsA-S Medication Solutions2024-10-14HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-7276-0Acyclovir90 in 1 BOTTLETABLET903
50090-7276-1Acyclovir21 in 1 BOTTLETABLET213

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-7276ACYCLOVIR TABLET [A-S MEDICATION SOLUTIONS]3Current NDC, 2 package rows20241015_b96e44ca-aa54-4a64-89f4-fb5a5932ceae.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-7276-0EA - Each50090-7276d6da1847-493e-4267-b194-80a528bc79bb12024-11-05
50090-7276-1EA - Each50090-7276c7c8da91-03d8-473b-bdfc-1b6ea23c441f12024-11-05

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 9 · 168 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ACYCLOVIRACYCLOVIRBryant Ranch Prepacke5356160-cb35-4ff6-91d5-2ade594e02792026-03-25Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRBryant Ranch Prepack69e5455e-d0be-4c2b-b9ab-458b5480ed572026-03-16Warnings, Adverse reactionsExact identifier
application number: ANDA210401
rxcui: 197311
unii: X4HES1O11F
acyclovirACYCLOVIRREMEDYREPACK INC.8fdabab2-bc93-48ab-9c13-d22ec90fdcfc2026-02-27Warnings, Adverse reactionsExact identifier
rxcui: 197311
unii: X4HES1O11F
AcyclovirACYCLOVIRFlorida Pharmaceutical Products, LLC3df7fa38-a869-45fb-98a3-81c5a2527d622026-02-18Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRMajor Pharmaceuticals46150f19-ce5d-42a0-80a7-f96fda2b98792026-02-18Warnings, Adverse reactionsExact identifier
rxcui: 197311
unii: X4HES1O11F
AcyclovirACYCLOVIRPreferred Pharmaceuticals, Inc.b6d69697-12bb-4548-a6c3-2463cbf54f8f2026-02-11Warnings, Adverse reactionsExact identifier
rxcui: 197313
unii: X4HES1O11F
AcyclovirACYCLOVIRA-S Medication Solutions2e6a3667-af06-40de-80c0-8c4346e0671f2026-02-08Warnings, Adverse reactionsExact identifier
application number: ANDA210401
rxcui: 197313
unii: X4HES1O11F
AcyclovirACYCLOVIRCamber Pharmaceuticals, Inc.0910335b-6796-459f-b97e-d7ef5439a0602026-02-02Warnings, Adverse reactionsExact identifier
rxcui: 197313
rxcui: 197311
unii: X4HES1O11F
acyclovirACYCLOVIRGlenmark Pharmaceuticals Inc., USA149f4418-7668-4d34-a6f9-69bf3a9c50492026-01-28Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
acyclovirACYCLOVIRANI Pharmaceuticals, Inc.8208711c-18ba-4615-b932-3c0bb7e6efae2026-01-23Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRActavis Pharma, Inc.a4c1305c-f18c-4fb0-83d8-2822341f2dfa2026-01-21Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRPreferred Pharmaceuticals Inc75334fc5-d236-401a-875c-f4f9c7749c1a2026-01-19Warnings, Adverse reactionsExact identifier
application number: ANDA210401
rxcui: 197311
unii: X4HES1O11F
acyclovirACYCLOVIRPreferred Pharmaceuticals Incc11c1136-7421-48ff-86d2-39507e80a04c2026-01-15Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRPreferred Pharmaceuticals Inc.b1033fda-8242-4006-b1cd-23474d70671f2026-01-15Warnings, Adverse reactionsExact identifier
rxcui: 197311
unii: X4HES1O11F
AcyclovirACYCLOVIRAvPAK6e203fa9-ee97-1e08-8d6a-fb57cfa13e192026-01-08Warnings, Adverse reactionsExact identifier
rxcui: 197313
rxcui: 197311
unii: X4HES1O11F
AcyclovirACYCLOVIRCadila Pharmaceuticals Limiteddbaf4bf5-57e3-4770-a9b2-d47649e54c1b2026-01-02Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRNorthwind Health Company, LLC5dcfd21c-43f0-469c-be70-a4e74e6ccf882026-01-01Warnings, Adverse reactionsExact identifier
rxcui: 197311
unii: X4HES1O11F
AcyclovirACYCLOVIRNorthwind Health Company, LLCf6f56143-ea74-af87-e053-6394a90ae3462026-01-01Warnings, Adverse reactionsExact identifier
rxcui: 197313
unii: X4HES1O11F
acyclovirACYCLOVIRNorthwind Health Company, LLCff9776b3-a248-e1ea-e053-6294a90aeb7b2026-01-01Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRYILING PHARMACEUTICAL, INC.67e7b340-0635-2595-e053-2a91aa0ad2662025-12-30Warnings, Adverse reactionsExact identifier
application number: ANDA210401
rxcui: 197313
unii: X4HES1O11F

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.